Sanofi To Extend Factory Despite Recent Problems

BMI View: Algeria is currently a high risk market for multinational drugmakers because of the combination of regional political uncertainty and state interference in its business environment. The country's protectionist import policies, together with its failure to anticipate consumer demands, are expected to damage total drug sales in 2011. Nevertheless, BMI remains optimistic about the overall market's future growth prospects.

To read the full article, please choose one of the following options: